Loss of FAT1 drives cyclophosphamide resistance in breast cancer via the Wnt/β-Catenin pathway
Lijing Zhong(Ningbo University), Dongxi Xiang(Brigham and Women's Hospital), Shasha Zhao(Chinese General Hospital College of Nursing and Liberal Arts), Gengming Niu(Institute for Biomedicine), Jian Zhang(Center for Excellence in Molecular Cell Science), Jingyuan Wen(University of Auckland), Li-Yi Zhang(Institute of Pomology), Dongyan Cao(Shanghai Cancer Institute), Yuxuan Xu(Renji Hospital), Paul W. R. Harris(Maurice Wilkins Centre), Aina He(Shanghai Sixth People's Hospital), Guiying Wei, Heming Xu, Xiao Liu(Qingdao University), Xuan Tang(Chinese Academy of Sciences)
Cited by 0
Related Papers
Single-cell RNA-sequencing atlas reveals an MDK-dependent immunosuppressive environment in ErbB pathway-mutated gallbladder cancer
|Journal of Hepatology|2021|215
Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells
|International Journal of Nanomedicine|2014|166
Extracellular Vesicles Released from Human Umbilical Cord-Derived Mesenchymal Stromal Cells Prevent Life-Threatening Acute Graft-Versus-Host Disease in a Mouse Model of Allogeneic Hematopoietic Stem Cell Transplantation
|Stem Cells and Development|2016|149
Single‐cell landscape and clinical outcomes of infiltrating B cells in colorectal cancer
|Immunology|2022|136
In vivo CRISPR screening unveils histone demethylase UTX as an important epigenetic regulator in lung tumorigenesis
|Proceedings of the National Academy of Sciences|2018|97